AMTIXBIO CO., LTD.
PrivateLast Round
VC Round
Dec 1, 2022
Est. Valuation
$186.29M
Total Funding Raised
$1.79M
Company Overview
AMTIXBIO CO., LTD. is a biotechnology company that develops innovative antifungal drugs and microbiome-based dermacosmetic products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMTIXBIO CO., LTD. Comparables
Compare AMTIXBIO CO., LTD. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elion Therapeutics | 76% | |
| Bright Angel Therapeutics | 75% | |
| F2G | 73% |
For institutional investors. Book with your work email.
AMTIXBIO CO., LTD. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 1, 2022 | ||||
| Series C | Jun 1, 2021 | ||||
| Series B | Feb 1, 2019 | ||||
| Series A | May 16, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AMTIXBIO CO., LTD. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUAD Investment Management | Series C |
| HG Initiative | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2021
Raised Series C round with Quad Asset Management and HG Initiative.
- Feb 1, 2019
Completed a Series B funding round.
For institutional investors. Book with your work email.
AMTIXBIO CO., LTD. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AMTIXBIO CO., LTD.'s valuation, stock price, and market status.
Is AMTIXBIO CO., LTD. a public or private company?
AMTIXBIO CO., LTD. is a private company.
What is the current stock price of AMTIXBIO CO., LTD.?
AMTIXBIO CO., LTD. is a private company, so its shares have no public market price. Caplight tracks AMTIXBIO CO., LTD.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AMTIXBIO CO., LTD. worth (valuation)?
AMTIXBIO CO., LTD.'s valuation is estimated at $186.3M based on funding round data.
Can I buy AMTIXBIO CO., LTD. stock?
AMTIXBIO CO., LTD. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AMTIXBIO CO., LTD.'s last funding round?
AMTIXBIO CO., LTD.'s most recent funding round was VC Round on December 1, 2022.
Who are the main investors in AMTIXBIO CO., LTD.?
Key investors in AMTIXBIO CO., LTD. include QUAD Investment Management, HG Initiative.
Will AMTIXBIO CO., LTD. IPO soon?
No public IPO plans have been announced for AMTIXBIO CO., LTD..
How can I track AMTIXBIO CO., LTD. secondary market activity?
Caplight tracks bids, offers, and trades in AMTIXBIO CO., LTD.'s shares on secondary markets.